The role of bispecific antibodies in the treatment landscape for R/R ...
Bispecific antibodies in NHL - VJHemOnc
Where do bispecific antibodies fit into the large cell lymphoma treatment landscape? ... R/R CLL. Mazyar Shadman • 1 Jun 2024 · 1:18. CELESTIAL ...
The evolving treatment landscape of R/R LBCL - VJHemOnc
These include bispecific antibodies such as mosunetuzumab and glofitamab, and studies have reported high efficacy with a highly manageable ...
Sandoz receives European Commission approval for Afqlir ...
[3] Galindo-Camacho RM, Blanco-Llamero C, da Ana R, Fuertes MA, Señoráns FJ, Silva AM, García ML, Souto EB. Therapeutic Approaches for Age- ...
iwNHL 2023 | Evolving treatment landscape of MCL - VJHemOnc
Discuss the evolving treatment landscape of mantle cell lymphoma (MCL), commenting on the impact of novel therapies in this disease.
Ratio Enters License and Collaboration Agreement with Novartis for ...
(Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and ...